1. |
Willott RH, Gomes AV, Chang AN, et al. Mutations in troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function. J Mol Cell Cardiol 2010; 48:882-92.
|
2. |
Kimberling MT, Balzer DT, Hirsch R, et al. Cardiac trans- plantation for pediatric restrictive cardiomyopathy: presen- tation, evaluation, and short-term outcome. J Heart Lung Transplant 2002; 21:455-9.
|
3. |
Peddy SB, Vricella LA, Crosson JE, et al. Infantile rest- rictive cardiomyopathy resulting from a mutation in the cardiac troponin T gene. Pediatrics 2006; 117:1830-3.
|
4. |
Greenway SC, Wilson GJ, Wilson J, et al. Sudden death in an infant with angina, restrictive cardiomyopathy, and coronary artery bridging: an unusual phenotype for a beta-myosin heavy chain (MYH7) sarcomeric protein mutation. Circ Heart Fail 2012; 5:e92-3.
|
5. |
Rivenes SM, Kearney DL, Smith EO, et al. Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. Circulation 2002; 102:876-82.
|
6. |
Palka P, Lange A, Ward C. A fatal case of idiopathic restrictive cardiomyopathy. Cardiol Young 2003; 13:469-71.
|
7. |
Jean-Charles PY, Li YJ, Nan CL, et al. Insights into restrictive cardiomyopathy from clinical and animal studies. J Geriatr Cardiol 2011; 8:168-83.
|
8. |
Parvatiyar MS, Pinto JR, Dweck D, et al. Cardiac troponin mutations and restrictive cardiomyopathy. J Biomed Biotechnol 2010; 2010:350706.
|
9. |
Peled Y, Gramlich M, Yoskovitz G, et al. Titin mutation in familial restrictive cardiomyopathy. Int J Cardiol 2014; 171:24-30.
|
10 |
Kamisago M, Sharma SD, DePalma SR, et al. Mutations in sarcomere protein genes as a cause of dilated cardio- myopathy. N Engl J Med 2003; 343:1688-96.
|
11 |
Chen J, Chien KR. Complexity in simplicity: monogenic disorders and complex cardiomyopathies. J Clin Invest 1999; 103:1483-5.
|
12 |
Mogensen J, Kubo T, Dugue M, et al. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. J Clin Invest 2003; 111:209-16.
|
13 |
Chen Y, Yang S, Li J, et al. Pediatric restrictive cardio- myopathy due to a heterozygous mutation of the TNNI3 gene. J Biomed Res 2014; 28:59-63.
|
14 |
Yang SW , Chen Y , Li J , et al. Clinical characteristics and genetic analysis of three pediatric patients with idiopathic restrictive cardiomyopathy. Zhonghua Xin Xue Guan Bing Za Zhi 2013; 41:304-9.
|
15 |
Mouton JM, Pellizzon AS, Goosen A, et al. Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo , in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy. Cardiovasc J Afr 2015; 26:63-9.
|
16 |
Kaski JP, Syrris P, Burch M, et al. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes. Heart 2008; 94:1478-84.
|
17 |
Wu W, Lu CX, Wang YN, et al. Novel phenotype-genotype correlations of restrictive cardiomyopathy with myosin- binding protein C (MYBPC3) gene mutations tested by next-generation sequencing. J Am Heart Assoc 2015; 4. pii: e001879.
|
18 |
Gomes AV, Liang J, Potter JD. Mutations in human cardiac troponin I that are associated with restrictive cardiomyopathy affect basal ATPase activity and the calcium sensitivity of force development. J Biol Chem 2005; 280:30909-15.
|
19 |
Yumoto F, Lu QW, Morimoto S, et al. Drastic Ca 2+ sensitization of myofilament associated with a small structural change in troponin I in inherited restrictive cardiomyopathy. Biochem Biophys Res Commun 2005; 338:1519-26.
|
20 |
Wen Y, Xu Y, Wang Y, et al. Functional effects of a restri- ctive-cardiomyopathy-linked cardiac troponin I mutation (R145W) in transgenic mice. J Mol Biol 2009; 392: 1158-67.
|
21 |
Davey JW, Hohenlohe PA, Etter PD, et al. Genome-wide genetic marker discovery and genotyping using next- generation sequencing. Nat Rev Genet 2011; 12:499-510.
|
22 |
Faita F, Vecoli C, Foffa I, et al. Next generation sequencing in cardiovascular diseases. World J Cardiol 2012; 4: 288-95.
|